1h Free Analyst Time
The global autoimmune drugs market is forecasted to grow by USD 38.22 billion during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of autoimmune disorders and increased diagnostic capabilities, transition toward precision-targeted biologics and advanced monoclonal antibodies, proliferation of biosimilars and favorable regulatory frameworks.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global autoimmune drugs market is segmented as below:
By Therapy Area
- Rheumatoid arthritis
- Multiple sclerosis
- Psoriasis
- Inflammatory bowel disease
- Others
By Distribution Channel
- Hospital
- Pharmacy
- Retail pharmacy
- Online
By Route Of Administration
- Injectable
- Oral
- Topical
By Drug Class
- Biologics and biosimilars
- Small molecules and JAK inhibitors
- Immunosuppressants
- Corticosteroids and NSAIDs
- Interferons
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global autoimmune drugs market covers the following areas:
- Global autoimmune drugs market sizing
- Global autoimmune drugs market forecast
- Global autoimmune drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Therapy Area
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Autoimmune Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Autoimmune Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Therapy Area Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global autoimmune drugs market
6.2 Impact of geopolitical conflicts on global autoimmune drugs market
6.2 Impact of geopolitical conflicts on global autoimmune drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Therapy Area
8.1 Market segments
- Chart on Therapy Area - Market share 2025-2030 (%)
- Data Table on Therapy Area - Market share 2025-2030 (%)
- Chart on Comparison by Therapy Area
- Data Table on Comparison by Therapy Area
- Chart on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million)
- Data Table on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million)
- Chart on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%)
- Data Table on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%)
- Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
- Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
- Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
- Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
- Chart on Psoriasis - Market size and forecast 2025-2030 ($ million)
- Data Table on Psoriasis - Market size and forecast 2025-2030 ($ million)
- Chart on Psoriasis - Year-over-year growth 2025-2030 (%)
- Data Table on Psoriasis - Year-over-year growth 2025-2030 (%)
- Chart on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million)
- Data Table on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million)
- Chart on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%)
- Data Table on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Therapy Area ($ million)
- Data Table on Market opportunity by Therapy Area ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital - Year-over-year growth 2025-2030 (%)
- Chart on Pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Online - Market size and forecast 2025-2030 ($ million)
- Data Table on Online - Market size and forecast 2025-2030 ($ million)
- Chart on Online - Year-over-year growth 2025-2030 (%)
- Data Table on Online - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Topical - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical - Market size and forecast 2025-2030 ($ million)
- Chart on Topical - Year-over-year growth 2025-2030 (%)
- Data Table on Topical - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Drug Class
11.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million)
- Data Table on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million)
- Chart on Biologics and biosimilars - Year-over-year growth 2025-2030 (%)
- Data Table on Biologics and biosimilars - Year-over-year growth 2025-2030 (%)
- Chart on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%)
- Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ million)
- Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ million)
- Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%)
- Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%)
- Chart on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million)
- Data Table on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million)
- Chart on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%)
- Data Table on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%)
- Chart on Interferons - Market size and forecast 2025-2030 ($ million)
- Data Table on Interferons - Market size and forecast 2025-2030 ($ million)
- Chart on Interferons - Year-over-year growth 2025-2030 (%)
- Data Table on Interferons - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Rising prevalence of autoimmune disorders and increased diagnostic capabilities
- Transition toward precision-targeted biologics and advanced monoclonal antibodies
- Proliferation of biosimilars and favorable regulatory frameworks
- Exorbitant treatment costs and severe reimbursement constraints
- Complex manufacturing requirements and vulnerable global supply chains
- Stringent regulatory hurdles and patent cliff pressures
- Impact of drivers and challenges in 2025 and 2030
- Integration of AI and ML in drug discovery
- Expansion of subcutaneous delivery systems and self-administered formulations
- Accelerated penetration of biosimilars across emerging and developed geographies
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Business segments
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- Gilead Sciences Inc. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Business segments
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- Takeda Pharmaceutical Ltd. - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Autoimmune Drugs Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Therapy Area Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Therapy Area - Market share 2025-2030 (%)
Exhibit 41: Data Table on Therapy Area - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Therapy Area
Exhibit 43: Data Table on Comparison by Therapy Area
Exhibit 44: Chart on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Psoriasis - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Psoriasis - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Psoriasis - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Psoriasis - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Therapy Area ($ million)
Exhibit 65: Data Table on Market opportunity by Therapy Area ($ million)
Exhibit 66: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 67: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Distribution Channel
Exhibit 69: Data Table on Comparison by Distribution Channel
Exhibit 70: Chart on Hospital - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Hospital - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Hospital - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Hospital - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Distribution Channel ($ million)
Exhibit 87: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 88: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 89: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 90: Chart on Comparison by Route of Administration
Exhibit 91: Data Table on Comparison by Route of Administration
Exhibit 92: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 100: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 104: Market opportunity by Route of Administration ($ million)
Exhibit 105: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 106: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 107: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 108: Chart on Comparison by Drug Class
Exhibit 109: Data Table on Comparison by Drug Class
Exhibit 110: Chart on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Data Table on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Chart on Biologics and biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Biologics and biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 114: Chart on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 122: Chart on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Data Table on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Chart on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%)
Exhibit 125: Data Table on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%)
Exhibit 126: Chart on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Data Table on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Chart on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 129: Data Table on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 130: Market opportunity by Drug Class ($ million)
Exhibit 131: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 132: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 133: Chart on Market share by geography 2025-2030 (%)
Exhibit 134: Data Table on Market share by geography 2025-2030 (%)
Exhibit 135: Chart on Geographic comparison
Exhibit 136: Data Table on Geographic comparison
Exhibit 137: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Regional Comparison - North America
Exhibit 142: Data Table on Regional Comparison - North America
Exhibit 143: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Regional Comparison - Europe
Exhibit 160: Data Table on Regional Comparison - Europe
Exhibit 161: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Regional Comparison - Asia
Exhibit 190: Data Table on Regional Comparison - Asia
Exhibit 191: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 212: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 213: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 214: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 215: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 216: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 217: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 218: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 219: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 220: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 221: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 242: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 243: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 245: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 246: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 247: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 248: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 249: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 250: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 251: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 252: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 253: Market opportunity by geography ($ million)
Exhibit 254: Data Tables on Market opportunity by geography ($ million)
Exhibit 255: Impact of drivers and challenges in 2025 and 2030
Exhibit 256: Overview on criticality of inputs and factors of differentiation
Exhibit 257: Overview on factors of disruption
Exhibit 258: Impact of key risks on business
Exhibit 259: Companies covered
Exhibit 260: Company ranking index
Exhibit 261: Matrix on companies position and classification
Exhibit 262: AbbVie Inc. - Overview
Exhibit 263: AbbVie Inc. - Business segments
Exhibit 264: AbbVie Inc. - Key news
Exhibit 265: AbbVie Inc. - Key offerings
Exhibit 266: AbbVie Inc. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Amgen Inc. - Overview
Exhibit 269: Amgen Inc. - Product / Service
Exhibit 270: Amgen Inc. - Key news
Exhibit 271: Amgen Inc. - Key offerings
Exhibit 272: SWOT
Exhibit 273: AstraZeneca Plc - Overview
Exhibit 274: AstraZeneca Plc - Business segments
Exhibit 275: AstraZeneca Plc - Key news
Exhibit 276: AstraZeneca Plc - Key offerings
Exhibit 277: AstraZeneca Plc - Segment focus
Exhibit 278: SWOT
Exhibit 279: Bayer AG - Overview
Exhibit 280: Bayer AG - Business segments
Exhibit 281: Bayer AG - Key news
Exhibit 282: Bayer AG - Key offerings
Exhibit 283: Bayer AG - Segment focus
Exhibit 284: SWOT
Exhibit 285: Bristol Myers Squibb Co. - Overview
Exhibit 286: Bristol Myers Squibb Co. - Product / Service
Exhibit 287: Bristol Myers Squibb Co. - Key news
Exhibit 288: Bristol Myers Squibb Co. - Key offerings
Exhibit 289: SWOT
Exhibit 290: Eli Lilly and Co. - Overview
Exhibit 291: Eli Lilly and Co. - Product / Service
Exhibit 292: Eli Lilly and Co. - Key news
Exhibit 293: Eli Lilly and Co. - Key offerings
Exhibit 294: SWOT
Exhibit 295: F. Hoffmann La Roche Ltd. - Overview
Exhibit 296: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 297: F. Hoffmann La Roche Ltd. - Key news
Exhibit 298: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 299: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 300: SWOT
Exhibit 301: Gilead Sciences Inc. - Overview
Exhibit 302: Gilead Sciences Inc. - Business segments
Exhibit 303: Gilead Sciences Inc. - Key news
Exhibit 304: Gilead Sciences Inc. - Key offerings
Exhibit 305: Gilead Sciences Inc. - Segment focus
Exhibit 306: SWOT
Exhibit 307: GlaxoSmithKline Plc - Overview
Exhibit 308: GlaxoSmithKline Plc - Business segments
Exhibit 309: GlaxoSmithKline Plc - Key news
Exhibit 310: GlaxoSmithKline Plc - Key offerings
Exhibit 311: GlaxoSmithKline Plc - Segment focus
Exhibit 312: SWOT
Exhibit 313: Johnson and Johnson - Overview
Exhibit 314: Johnson and Johnson - Business segments
Exhibit 315: Johnson and Johnson - Key news
Exhibit 316: Johnson and Johnson - Key offerings
Exhibit 317: Johnson and Johnson - Segment focus
Exhibit 318: SWOT
Exhibit 319: Merck KGaA - Overview
Exhibit 320: Merck KGaA - Business segments
Exhibit 321: Merck KGaA - Key news
Exhibit 322: Merck KGaA - Key offerings
Exhibit 323: Merck KGaA - Segment focus
Exhibit 324: SWOT
Exhibit 325: Novartis AG - Overview
Exhibit 326: Novartis AG - Business segments
Exhibit 327: Novartis AG - Key news
Exhibit 328: Novartis AG - Key offerings
Exhibit 329: Novartis AG - Segment focus
Exhibit 330: SWOT
Exhibit 331: Pfizer Inc. - Overview
Exhibit 332: Pfizer Inc. - Business segments
Exhibit 333: Pfizer Inc. - Key news
Exhibit 334: Pfizer Inc. - Key offerings
Exhibit 335: Pfizer Inc. - Segment focus
Exhibit 336: SWOT
Exhibit 337: Sanofi SA - Overview
Exhibit 338: Sanofi SA - Business segments
Exhibit 339: Sanofi SA - Key news
Exhibit 340: Sanofi SA - Key offerings
Exhibit 341: Sanofi SA - Segment focus
Exhibit 342: SWOT
Exhibit 343: Takeda Pharmaceutical Ltd. - Overview
Exhibit 344: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 345: Takeda Pharmaceutical Ltd. - Key news
Exhibit 346: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 347: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 348: SWOT
Exhibit 349: Inclusions checklist
Exhibit 350: Exclusions checklist
Exhibit 351: Currency conversion rates for US$
Exhibit 352: Research methodology
Exhibit 353: Information sources
Exhibit 354: Data validation
Exhibit 355: Validation techniques employed for market sizing
Exhibit 356: Data synthesis
Exhibit 357: 360 degree market analysis
Exhibit 358: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Autoimmune Drugs Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Therapy Area Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Therapy Area - Market share 2025-2030 (%)
Exhibit 41: Data Table on Therapy Area - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Therapy Area
Exhibit 43: Data Table on Comparison by Therapy Area
Exhibit 44: Chart on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Rheumatoid arthritis - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Rheumatoid arthritis - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Psoriasis - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Psoriasis - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Psoriasis - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Psoriasis - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Inflammatory bowel disease - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Inflammatory bowel disease - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Therapy Area ($ million)
Exhibit 65: Data Table on Market opportunity by Therapy Area ($ million)
Exhibit 66: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 67: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Distribution Channel
Exhibit 69: Data Table on Comparison by Distribution Channel
Exhibit 70: Chart on Hospital - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Hospital - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Hospital - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Hospital - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Distribution Channel ($ million)
Exhibit 87: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 88: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 89: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 90: Chart on Comparison by Route of Administration
Exhibit 91: Data Table on Comparison by Route of Administration
Exhibit 92: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 100: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 104: Market opportunity by Route of Administration ($ million)
Exhibit 105: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 106: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 107: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 108: Chart on Comparison by Drug Class
Exhibit 109: Data Table on Comparison by Drug Class
Exhibit 110: Chart on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million)
Exhibit 111: Data Table on Biologics and biosimilars - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Chart on Biologics and biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 113: Data Table on Biologics and biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 114: Chart on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Small molecules and JAK inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Small molecules and JAK inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Immunosuppressants - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Data Table on Immunosuppressants - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Chart on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Immunosuppressants - Year-over-year growth 2025-2030 (%)
Exhibit 122: Chart on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Data Table on Corticosteroids and NSAIDs - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Chart on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%)
Exhibit 125: Data Table on Corticosteroids and NSAIDs - Year-over-year growth 2025-2030 (%)
Exhibit 126: Chart on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Data Table on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Chart on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 129: Data Table on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 130: Market opportunity by Drug Class ($ million)
Exhibit 131: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 132: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 133: Chart on Market share by geography 2025-2030 (%)
Exhibit 134: Data Table on Market share by geography 2025-2030 (%)
Exhibit 135: Chart on Geographic comparison
Exhibit 136: Data Table on Geographic comparison
Exhibit 137: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Regional Comparison - North America
Exhibit 142: Data Table on Regional Comparison - North America
Exhibit 143: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Regional Comparison - Europe
Exhibit 160: Data Table on Regional Comparison - Europe
Exhibit 161: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Regional Comparison - Asia
Exhibit 190: Data Table on Regional Comparison - Asia
Exhibit 191: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 212: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 213: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 214: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 215: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 216: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 217: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 218: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 219: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 220: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 221: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 242: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 243: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 245: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 246: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 247: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 248: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 249: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 250: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 251: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 252: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 253: Market opportunity by geography ($ million)
Exhibit 254: Data Tables on Market opportunity by geography ($ million)
Exhibit 255: Impact of drivers and challenges in 2025 and 2030
Exhibit 256: Overview on criticality of inputs and factors of differentiation
Exhibit 257: Overview on factors of disruption
Exhibit 258: Impact of key risks on business
Exhibit 259: Companies covered
Exhibit 260: Company ranking index
Exhibit 261: Matrix on companies position and classification
Exhibit 262: AbbVie Inc. - Overview
Exhibit 263: AbbVie Inc. - Business segments
Exhibit 264: AbbVie Inc. - Key news
Exhibit 265: AbbVie Inc. - Key offerings
Exhibit 266: AbbVie Inc. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Amgen Inc. - Overview
Exhibit 269: Amgen Inc. - Product / Service
Exhibit 270: Amgen Inc. - Key news
Exhibit 271: Amgen Inc. - Key offerings
Exhibit 272: SWOT
Exhibit 273: AstraZeneca Plc - Overview
Exhibit 274: AstraZeneca Plc - Business segments
Exhibit 275: AstraZeneca Plc - Key news
Exhibit 276: AstraZeneca Plc - Key offerings
Exhibit 277: AstraZeneca Plc - Segment focus
Exhibit 278: SWOT
Exhibit 279: Bayer AG - Overview
Exhibit 280: Bayer AG - Business segments
Exhibit 281: Bayer AG - Key news
Exhibit 282: Bayer AG - Key offerings
Exhibit 283: Bayer AG - Segment focus
Exhibit 284: SWOT
Exhibit 285: Bristol Myers Squibb Co. - Overview
Exhibit 286: Bristol Myers Squibb Co. - Product / Service
Exhibit 287: Bristol Myers Squibb Co. - Key news
Exhibit 288: Bristol Myers Squibb Co. - Key offerings
Exhibit 289: SWOT
Exhibit 290: Eli Lilly and Co. - Overview
Exhibit 291: Eli Lilly and Co. - Product / Service
Exhibit 292: Eli Lilly and Co. - Key news
Exhibit 293: Eli Lilly and Co. - Key offerings
Exhibit 294: SWOT
Exhibit 295: F. Hoffmann La Roche Ltd. - Overview
Exhibit 296: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 297: F. Hoffmann La Roche Ltd. - Key news
Exhibit 298: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 299: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 300: SWOT
Exhibit 301: Gilead Sciences Inc. - Overview
Exhibit 302: Gilead Sciences Inc. - Business segments
Exhibit 303: Gilead Sciences Inc. - Key news
Exhibit 304: Gilead Sciences Inc. - Key offerings
Exhibit 305: Gilead Sciences Inc. - Segment focus
Exhibit 306: SWOT
Exhibit 307: GlaxoSmithKline Plc - Overview
Exhibit 308: GlaxoSmithKline Plc - Business segments
Exhibit 309: GlaxoSmithKline Plc - Key news
Exhibit 310: GlaxoSmithKline Plc - Key offerings
Exhibit 311: GlaxoSmithKline Plc - Segment focus
Exhibit 312: SWOT
Exhibit 313: Johnson and Johnson - Overview
Exhibit 314: Johnson and Johnson - Business segments
Exhibit 315: Johnson and Johnson - Key news
Exhibit 316: Johnson and Johnson - Key offerings
Exhibit 317: Johnson and Johnson - Segment focus
Exhibit 318: SWOT
Exhibit 319: Merck KGaA - Overview
Exhibit 320: Merck KGaA - Business segments
Exhibit 321: Merck KGaA - Key news
Exhibit 322: Merck KGaA - Key offerings
Exhibit 323: Merck KGaA - Segment focus
Exhibit 324: SWOT
Exhibit 325: Novartis AG - Overview
Exhibit 326: Novartis AG - Business segments
Exhibit 327: Novartis AG - Key news
Exhibit 328: Novartis AG - Key offerings
Exhibit 329: Novartis AG - Segment focus
Exhibit 330: SWOT
Exhibit 331: Pfizer Inc. - Overview
Exhibit 332: Pfizer Inc. - Business segments
Exhibit 333: Pfizer Inc. - Key news
Exhibit 334: Pfizer Inc. - Key offerings
Exhibit 335: Pfizer Inc. - Segment focus
Exhibit 336: SWOT
Exhibit 337: Sanofi SA - Overview
Exhibit 338: Sanofi SA - Business segments
Exhibit 339: Sanofi SA - Key news
Exhibit 340: Sanofi SA - Key offerings
Exhibit 341: Sanofi SA - Segment focus
Exhibit 342: SWOT
Exhibit 343: Takeda Pharmaceutical Ltd. - Overview
Exhibit 344: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 345: Takeda Pharmaceutical Ltd. - Key news
Exhibit 346: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 347: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 348: SWOT
Exhibit 349: Inclusions checklist
Exhibit 350: Exclusions checklist
Exhibit 351: Currency conversion rates for US$
Exhibit 352: Research methodology
Exhibit 353: Information sources
Exhibit 354: Data validation
Exhibit 355: Validation techniques employed for market sizing
Exhibit 356: Data synthesis
Exhibit 357: 360 degree market analysis
Exhibit 358: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global autoimmune drugs market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bausch Health Co Inc., Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Celltrion Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Johnson and Johnson, LEO Pharma AS, Merck KGaA, Novartis AG, Organon and Co., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Ltd., UCB SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of ai and ml in drug discovery."
According to the report, one of the major drivers for this market is the rising prevalence of autoimmune disorders and increased diagnostic capabilities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bausch Health Co Inc.
- Bayer AG
- Biogen Inc.
- Bristol Myers Squibb Co.
- Celltrion Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Incyte Corp.
- Johnson and Johnson
- LEO Pharma AS
- Merck KGaA
- Novartis AG
- Organon and Co.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Takeda Pharmaceutical Ltd.
- UCB SA
